NCT05592366 Dementia Care Partner Hospital Assessment Tool
| NCT ID | NCT05592366 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Alzheimer Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 128 participants |
| Start Date | 2024-04-02 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 128 participants in total. It began in 2024-04-02 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to see whether an adapted questionnaire called the Care Partner Hospital Assessment Tool (CHAT) for care partners of hospitalized patients living with Alzheimer's disease and related dementias (ADRD) (CHAT-AD) can help people with dementia receive better care after they go home from the hospital. Participants will be a care partner ('family member or friend') who provides unpaid care to a hospitalized adult relative or partner to help them take care of themselves because of dementia. Participants can expect to be in this study for 14 days.
Eligibility Criteria
Inclusion Criteria: * Provide unpaid care to a hospitalized adult relative or partner to help them take care of themselves because of ADRD * 18 years or older Exclusion Criteria: * Non-English speaking
Contact & Investigator
Beth Fields, PhD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT05592366 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05592366 currently recruiting?
Yes, NCT05592366 is actively recruiting participants. Contact the research team at amortensen3@wisc.edu for enrollment information.
Where is the NCT05592366 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT05592366 clinical trial?
NCT05592366 is sponsored by University of Wisconsin, Madison. The principal investigator is Beth Fields, PhD at University of Wisconsin, Madison. The trial plans to enroll 128 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.